Who owns the STDPHARM trademark?

The STDPHARM trademark is owned by Standardpharm Co., Ltd.

What class is the STDPHARM trademark registered in?

The STDPHARM trademark is registered in Class 042 (Scientific, technology & SaaS services).

What is the serial number for STDPHARM?

The USPTO serial number for STDPHARM is 97923499.

What is the registration number for STDPHARM?

STDPHARM is registered under USPTO registration number 7950755.

Sealvo

Home Search: STDPHARMSTDPHARM #97923499

Back

Updated Oct 6, 2026·33 searches this week

View on USPTO TSDR Find similar marks

STD

USPTO Trademark Record

REGISTERED

STDPHARM

SN 97923499·Reg 7950755·Filed May 05, 2023

Owner Standardpharm Co., Ltd

Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

STDPHARM (Serial No. 97923499), Registration No. 7950755, is a registered US trademark filed on May 05, 2023 by Standardpharm Co., Ltd. This trademark covers Class 042 (Scientific, technology & SaaS services).

early section 8: September 16, 2031

Mark Intelligence

STDPHARM (Reg. #7950755) is a registered US trademark that has been protecting its owner, Standardpharm Co., Ltd, since 2023. The mark covers Class 042 (Scientific, technology & SaaS services). Goods and services include Scientific and technological services and research and design relating thereto; industrial analysis, industrial research.... The mark faced 1 opposition proceeding during prosecution.

FILED

May 05, 2023

SERIAL

97923499

REG#

7950755

REGISTERED

Sep 16, 2025

Filing Information

StatusREGISTERED

Filing DateMay 05, 2023

Serial Number97923499

Registration No.7950755

Registration DateSep 16, 2025

Status DateSep 16, 2025

Published for OppositionOct 22, 2024

Filing Basis & Declarations

Filed as Use ApplicationUse Application Currently

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 042Scientific, technology & SaaS services

US codes: 100, 101

First use anywhere: Jan 01, 2021

First use in commerce: Jan 01, 2021

This description is as filed with the USPTO and defines the scope of trademark protection.

Run a conflict check

Search by serial number, mark name, or logo. See conflicting marks ranked by risk with clear explanations of what contributed.

Run conflict check

Status History

25 events

REGISTERED-PRINCIPAL REGISTER

Sep 16, 2025

REGISTERED-PRINCIPAL REGISTER

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Sep 16, 2025

NOTICE OF REGISTRATION CONFIRMATION EMAILED

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Sep 03, 2025

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

Aug 28, 2025

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

STATEMENT OF USE PROCESSING COMPLETE

Aug 27, 2025

STATEMENT OF USE PROCESSING COMPLETE

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Aug 26, 2025

CASE ASSIGNED TO INTENT TO USE PARALEGAL

TEAS STATEMENT OF USE RECEIVED

Jan 12, 2025

TEAS STATEMENT OF USE RECEIVED

USE AMENDMENT FILED

Jan 12, 2025

USE AMENDMENT FILED

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Dec 03, 2024

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

PUBLISHED FOR OPPOSITION

Oct 22, 2024

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Oct 22, 2024

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Oct 02, 2024

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

APPROVED FOR PUB - PRINCIPAL REGISTER

Sep 12, 2024

APPROVED FOR PUB - PRINCIPAL REGISTER

ASSIGNED TO LIE

Sep 10, 2024

ASSIGNED TO LIE

Sep 10, 2024

ASSIGNED TO LIE

CORRESPONDENCE RECEIVED IN LAW OFFICE

Sep 10, 2024

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Sep 10, 2024

TEAS/EMAIL CORRESPONDENCE ENTERED

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Apr 17, 2024

TEAS RESPONSE TO OFFICE ACTION RECEIVED

ASSIGNED TO EXAMINER

Jan 30, 2024

ASSIGNED TO EXAMINER

NON-FINAL ACTION WRITTEN

Jan 30, 2024

NON-FINAL ACTION WRITTEN

NON-FINAL ACTION E-MAILED

Jan 30, 2024

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Jan 30, 2024

NOTIFICATION OF NON-FINAL ACTION E-MAILED

NOTICE OF DESIGN SEARCH CODE E-MAILED

Jun 06, 2023

NOTICE OF DESIGN SEARCH CODE E-MAILED

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Jun 05, 2023

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

May 09, 2023

NEW APPLICATION ENTERED

Other Marks by Standardpharm Co., Ltd

Additional USPTO filings from the same owner.

STA

STANDARDPHARM

97923498

Standardpharm Co., Ltd

REGISTERED

STD

STDPHARM

90679254

Standardpharm Co., Ltd

REGISTERED

STA

STANDARDPHARM

90679553

Standardpharm Co., Ltd

REGISTERED

Other Marks by Zhirong Liu

Additional USPTO filings handled by the same attorney of record.

WAB

WABIWABI@HOME

97633918

REGISTERED

AND

ANDROMEDA

87664068

REGISTERED

UST

USTY

88736072

REGISTERED

MEN

MENGATE

90414934

REGISTERED

STDPHARM

Run a conflict check

Other Marks by Standardpharm Co., Ltd

Other Marks by Zhirong Liu

Get pre-filing clearance

Search 14M+ trademarks

Resources

Company